はじめての内科病棟 ただいま回診中!

出版社: 中外医学社
著者:
発行日: 2021-02-01
分野: 臨床医学:内科  >  内科学一般
ISBN: 9784498020924
電子書籍版: 2021-02-01 (1版1刷)
書籍・雑誌
≪全国送料無料でお届け≫
発送目安:4~8営業日

4,180 円(税込)

電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

4,180 円(税込)

商品紹介

医師になって初めての経験となる初期研修における内科病棟のローテーションは誰にとっても不安なもの.そのなかでもとくに重要な病棟回診における基本中のキホンをコモンな疾患(病態)の対処法と合わせて紹介.どの診療科でも必要となるさまざまなノウハウをわかりやすく解説する.また,研修医を指導する立場の医師に向けた章も設け,“内科病棟回診”に携わるすべての医師に役立つ全科共通の必読書!

目次

  • Dr. Branchより内科ローテーターへのメッセージ10か条

    CHAPTER 1 ● 全科共通  回診の基本と極意
     1-1 はじめて患者を受け持ったら
     1-2 入院時診療録を書く
     1-3 上手な病歴聴取とは
     1-4 病棟回診でのショートプレゼンテーション
     1-5 全身状態をみる
     1-6 上手な身体所見の取り方
     1-7 良い診療録の書き方
     1-8 積極的なリハビリテーションを促す
     1-9 バイタルサインはバイタル
     1-10 危機の予兆を敏感に察知するセンスを磨く
     1-11 上手なコンサルテーションをするには
     1-12 診療情報提供書でスムーズな引継ぎを
     1-13 患者さんの生活を知る
     1-14 患者さんの状態を把握する
     1-15 病棟回診を自分の成長につなげる

    CHAPTER 2 ● 内科コモン疾患の入院後の診かた
     2-1 肺炎患者の入院後の診かた
     2-2 尿路感染患者の入院後の診かた
     2-3 敗血症患者の入院後の診かた
     2-4 上部消化管出血患者の診かた
     2-5 ウィルス感染患者の診かた
     2-6 肺結核が疑われた患者の診かた

    CHAPTER 3 ● 教育回診の心得と極意
     3-1 教育回診 症例の選び方
     3-2 教育回診 準備と進め方
     3-3 教育回診 プレゼンテーション用スライドの作成
     3-4 教育回診 プレゼンテーション本番
     3-5 教育回診 キャリアアップにつなげよう

おすすめ商品

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

CHAPTER 1 全科共通 回診の基本と極意

P.5 掲載の参考文献
1) 江原淳. ホスピタリストのための入院診療総論. In : 平岡栄治, 江原淳, 編. レジデントノート増刊 ホスピタリスト直伝! 入院診療虎の巻. 東京 : 羊土社 ; 2019.
P.12 掲載の参考文献
1) 佐藤健太. 「型」が身につくカルテの書き方. 東京 : 医学書院 ; 2015.
2) 種井実佳. カルテ記載の心得. In : 徳田安春, 総監修. 新・総合診療医学 病院総合診療医学編. 第3版. さいたま : カイ書林 ; 2019.
3) 斎藤清二. ナラエビ医療学講座 : 物語と科学の統合を目指して. 京都 : 北大路書房 ; 2011.
4) 近藤直樹, 岩堀禎廣. 医療コミュニケーション―「スキル」を学ぶ前に読む本. 東京 : 薬事日報社 ; 2008.
P.23 掲載の参考文献
1) Towfigh S, McFadden DW, Cortina GR, et al. Porcelain gallbladder is not associated with gallbladder carcinoma. Am Surg. 2001 ; 67 : 7-10.
2) Stephen AE, Berger DL. Carcinoma in the porcelain gallbladder : a relationship revisited. Surgery. 2001 ; 129 : 699-703.
P.25 掲載の参考文献
1) 近藤直樹, 岩堀禎廣. 医療コミュニケーション-「スキル」を学ぶ前に読む本. 東京 : 薬事日報社 ; 2008.
P.29 掲載の参考文献
1) Pangaro L. A new vocabulary and other innovations for improving descriptive in-training evaluations. Acad Med. 1999 ; 74 : 1203-7.
P.33 掲載の参考文献
1) Chaiyachati KH, Shea JA, Asch DA, et al. Assessment of inpatient time allocation among first-year internal medicine residents using time-motion observations. JAMA Intern Med. 2019 ; 179 : 760-7.
2) Block L, Habicht R, Wu AW, et al. In the wake of the 2003 and 2011 duty hours regulations, how do internal medicine interns spend their time? J Gen Intern Med. 2013 ; 28 : 1042-7.
3) Croskerry P, Singhal G, Mamede S. Cognitive debiasing 1 : origins of bias and theory of debiasing. BMJ Qual Saf. 2013 ; 22 Suppl 2 : ii58-64.
4) 北川泉. 臨床推論と診断エラー. 湘南地区総合内科セミナー. 2017年3月28日.
P.42 掲載の参考文献
1) Creager MA, Loscalzo J. Vascular disease of the extremities. In : Jameson JL, Fauci AS, Kasper DL, et al. Harrison's principles of internal medicine. 17th ed. NY : McGraw-Hill ; 2008. p.1568-75.
2) 日比野真, 西口翔, 赤澤賢一郎, 他. 非典型的皮疹と急速進行性間質性肺炎で発症した抗CADM-140抗体陽性の皮膚筋炎の1例. 日呼雑誌. 2012 ; 1 : 27-34.
3) Rossi AM, Nodosum E. Erythema Nodosum. DynaMed Plus. Updated 2019 Jul 08.
4) 清水宏. 新しい皮膚科学. 第3版. 14章. 東京 : 中山書店 ; 2018 : p.264-5.
P.48 掲載の参考文献
1) 佐藤健太. 「型」が身につくカルテの書き方. 東京 : 医学書院 ; 2015.
P.51 掲載の参考文献
P.53 掲載の参考文献
1) 内閣府. 平成26年度高齢者の日常生活に関する意識調査. http://www8.cao.go.jp/kourei/ishiki/h26/sougou/zentai/index.html
2) Suzuki Y, Akishita M, Arai H, et al. Multiple consultations and polypharmacy of patients attending geriatric outpatient units of university hospitals. Geriatr Gerontol Int. 2006 ; 6 : 244-7.
3) Kojima T, Akishita M, Nakamura T, et al. Polypharmacy as a risk for fall occurrence in geriatric outpatients. Geriatr Gerontol Int. 2012 ; 12 : 425-30.
4) Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia : European consensus on definition and diagnosis : report of the European Working Group on sarcopenia in older people. Age Ageing. 2010 ; 39 : 412-23.
P.67 掲載の参考文献
1) 北川泉. <医師-医師> 救急外来-下級医から上級医. JIM. 2012 ; 22 : 194-7.
P.72 掲載の参考文献
1) Kripalani S, LeFevre F, Phillips CO, et al. Deficits in communication and information transfer between hospital-based and primary care physicians : implications for patient safety and continuity of care. JAMA. 2007 ; 297 : 831-41.
2) 新森加奈子, 木村琢磨, 松村真司. 我が国におけるケア移行という概念 病院を退院した患者の診療所外来へのケア移行を中心に (総説). 日本プライマリ・ケア連合学会誌. 2018 ; 41 : 18-23.
3) Forster AJ, Murff HJ, Peterson JF, et al. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003 ; 138 : 161-7.
4) Legault K, Ostro J, Khalid Z, et al. Quality of discharge summaries prepared by first year internal medicine residents. BMC Med Educ. 2012 ; 12 : 77.
5) 日本老年医学会. 「ACP推進に関する提言」2019年. https://www.jpn-geriat-soc.or.jp/press_seminar/pdf/ACP_proposal.pdf
6) Bell CM, Schnipper JL, Auerbach AD, et al. Association of communication between hospital-based physicians and primary care providers with patient outcomes. J Gen Intern Med. 2009 ; 24 : 381-6.
7) Ways M, Umali J, Buchwald D. Frequency and impact of housestaff contact with primary care physicians. J Gen Intern Med. 1995 ; 10 : 688-90.
P.81 掲載の参考文献
1) 石山貴章. リーダーとしての能力 : 注目すべきemotional intelligence. Hospitalist. 2013 ; 1 : 65-71.
P.85 掲載の参考文献
1) Pangaro L. A new vocabulary and other innovations for improving descriptive in-training evaluations. Acad Med. 1999 ; 74 : 1203-7.

CHAPTER 2 内科コモン疾患の入院後の診かた

P.99 掲載の参考文献
1) Feldman C. Pneumonia in the elderly. Clin Chest Med. 1999 ; 20 : 563-73.
2) Teramoto S, Fukuchi Y, Sasaki H, et al. High incidence of aspiration pneumonia in community- and hospital-acquired pneumonia in hospitalized patients : a multicenter, prospective study in Japan. J Am Geriatr Soc. 2008 ; 56 : 577-9.
4) Lim WS, van der Eerden MM, Laing R, et al. Defining community-acquired pneumonia severity on presentation to hospital : an international derivation and validation study. Thorax. 2003 ; 58 : 377-82.
9) Overview of Pneumonias. 「Pneumonia Essentials 3rd edition」 (Cunha BA), Jones and Bartlett, 2010.
10) Lelubre C, Anselin S, Zouaoui Boudjeltia K, Biston P, Piagnerelli M. (2013) Interpretation of C-reactive protein concentrations in critically ill patients. Biomed Res Int. http://dx.doi.org/10.1155/2013/124021.
13) Mikasa K, Aoki N, Aoki Y, et al. JAID/JSC Guidelines for the Treatment of Respiratory Infectious Disease : The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy. J Infect Chemother. 2016 ; 22 : S1-65.
14) Greater Glasgow & Clyde Antimicrobial Utilisation Committee, June 2018. IV-Oral Antibiotic Switch Therapy (IVOST) Guideline. Review June 2021. https://handbook.ggcmedicines.org.uk/media/1031/antibiotic-iv-oralantibiotic-switch-therapy-1901f.pdf
15) Maruyama T, Taguchi O, Niederman SM, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents : double blind, randomised and placebo controlled trial. BMJ. 2010 ; 340 : c1004.
16) Deemicheli V, Jefferson T, Ferroni E, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2018 ; 2 : CD004876.
P.115 掲載の参考文献
2) Ulvik A. Multiple organ failure after trauma affects even long-term survival and functional status. Crit Care. 2007 ; 11 : 95.
3) Tokuda Y, Miyasato H, Stein HG, et al. The degree of chills for risk of bacteremia in acute febrile illness. Am J Med. 2005 ; 118 : 1417.
4) Johnson JR, Russo TA. Acute pyelonephritis in adults. N Engl J Med. 2018 ; 378 : 48-59.
5) Walter LJMD, Joris CY, Nico P van D, et al. The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. BMC Urol. 2004 ; 4 : 4.
6) Albersen M, Joniau S, Van Poppel H, et al. Urea-splitting urinary tract infection contributing to hyperammonemic encephalopathy. Nat Clin Pract Urol. 2007 ; 4 : 455-8.
7) 猪狩淳. 尿中細菌増殖におよぼす尿pH, 浸透圧の影響. 日本伝染病学会雑誌. 1969 ; 42 : 343-52.
8) Viroj W, Nibhond U, Chaiyaporn B. Diagnostic value and cost utility analysis for urine Gram stain and urine microscopic examination as screening tests for urinary tract infection. Urol Res. 2005 ; 33 : 220-2.
9) Neuville M, Hustinx R, Jacques J, et al. Diagnostic algorithm in the management of acute febrile abdomen in patients with autosomal dominant polycystic kidney disease. PLoS One. 2016 ; 11 : e0161277.
10) Nowosinska E, Navalkissoor S, Quigley MA, et al. Is there a role for gallium-67 citrate SPECT/CT, in patients with renal impairment or who are renal transplant recipients, in identifying and localizing suspected infection? World J Nucl Med. 2015 ; 14 : 184-8.
11) van Nieuwkoop C, Hoppe BPC, Bonten TN, et al. Predicting the need for radiologic imaging in adults with febrile urinary tract infection. Clin Infect Dis. 2010 ; 51 : 1266-72.
12) Hooton MT, Vecchio M, Iroz A, et al. Effect of increased daily water intake in premenopausal woman with recurrent urinary tract infections : a randomized clinical trial. JAMA Intern Med. 2018 ; 178 : 1509-15.
13) Lunchs JS, Katz DS, Lane MJ, et al. Utility of hematuria testing in patients with suspected renal colic : correlation with unenhanced helical CT results. Urology. 2002 ; 59 : 839-42.
14) Kwangsu P, Sang HK, Sun GA, et al. Analysis of the treatment of two types of acute urinary retention. Korean J Urol. 2012 ; 53 : 843-7.
15) Valdevenito JP, Arturo GM, Jorge R, et al. Correlation of xiphopubic distance, body weight, height and body mass index with intravesical and abdominal initial resting pressures in urodynamic testing in sitting position. Low urin tract symptoms. 2018 ; 10 : 271-6.
16) Naber KG, Llorens L, Kaniga K, et al. Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis. Antimicrob Agents Chemother. 2009 ; 53 : 3782-92.
17) Tomera KM, Burdmann EA, Reyna OGP, et al. Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults : results of a prospective, randomized, double-blind multicenter study. Antimicrob Agents Chemother. 2002 ; 46 : 2895-900.
18) Lo E, Nicolle L, Classen D, et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008 ; 29 : Suppl 1 : S41-50.
19) Kuriyama A, Takada T, Irie H, et al. Prevalence and appropriateness of urinary catheters in Japanese intensive care units : results from a multicenter point prevalence study. Clin Infect Dis. 2017 ; 64 : S127-30.
20) Sanjay S, M Todd G, Sarah L K, et al. A program to prevent catheter-associated urinary tract infection in acute care. N Engl J Med. 2016 ; 374 : 2111-9.
21) 峯山浩忠, 狩野健一, 武藤正樹, 他. 採尿バッグの赤紫化. 臨床泌尿器科. 1993 ; 47 : 789-90.
22) 中嶋孝, 木内弘道, 熊巳一夫, 他. 紫色採尿バッグ症候群14症例の検討. 臨床泌尿器科. 2007 ; 61 : 155-8.
23) 津村秀康, 佐藤威文, 大草洋, 他. Purple Urine Bag Syndromeの臨床像に関する検討. 泌尿器外科. 2005 ; 18 : 524.
24) 新垣義孝. 泌尿器科疾患 (特集 ERにおける腹部急性疾患の診療). 救急医学. 2010 ; 34 : 199-205.
25) Nishiguchi S, Branch J, Suganami Y, et al. Effectiveness of early ureteric stenting for urosepsis associated with urinary tract calculi. Intern Med. 2014 ; 53 : 2205-10.
P.123 掲載の参考文献
1) Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign : international guidelines for management of sepsis and septic shock : 2016. Crit Care Med. 2017 ; 45 : 486-552.
2) 日本救急医学会Sepsis Registry特別委員会. 日本救急医学会Sepsis Registry特別委員会報告Severe sepsis疫学データ解析結果. 日救急医学誌. 2013 ; 24 : 270-7.
3) Byuk SK, Sung HC, Gu HK, et al. Antibiotics and the outcome of patients with septic shock : a propensity score analysis. Am J Med. 2020 ; 133 : 485-91.
4) Singer M, Deutschman CS, Seymour CW, et al. The Third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016 ; 315 : 801-10.
5) Ulvik A. Multiple organ failure after trauma affects even long-term survival and functional status. Crit Care. 2007 ; 11 : 95.
6) Kalfon P, Le Manach Y, Ichai C, et al ; GAO-REA Study Group. Severe and multiple hypoglycemic episodes are associated with increased risk of death in ICU patients. Crit Care. 2015 ; 19 : 153.
7) Egi M, Bellomo R, Stachowski E, et al. Blood glucose concentration and outcome of critical illness : the impact of diabetes. Crit Cre Med. 2008 ; 36 : 2249-55.
9) 日本循環器学会. 感染性心内膜炎の予防と治療に関するガイドライン. 2017年改訂版.
10) Lopez J, Selvilla T, Vilacosta I, et al. Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis. Eur Heart J. 2013 ; 34 : 1749-54.
P.132 掲載の参考文献
1) Richards RJ, Donica MB, Grayer D. J Clin Gastroenterol. Can the blood urea nitrogen/creatinine ratio distinguish upper from lower gastrointestinal bleeding? 1990 ; 12 : 500-4.
2) Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes : a meta-analysis and systematic review. Am J Med. 2014 ; 127 : 124-31.e3.
3) 矢花剛, 小林壮光, 杉山敏郎. 消化性潰瘍 : 診断と治療の進歩 プロトンポンプ阻害薬とH2ブロッカーの使い方. 日本内科学会雑誌. 1995 ; 84 : 905-10.
4) 藤本一眞, 藤城光弘, 加藤元嗣, 他. 抗血栓薬服用者に対する消化器内視鏡診療ガイドライン. 日本消化器内視鏡学会雑誌. 2012 ; 54 : 2075-102.
5) Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic-ulcer disease : a meta-analysis. Lancet. 2002 ; 359 : 14-22.
6) 加藤元嗣, 上堂文也, 掃本誠治, 他. 抗血栓薬服用者に対する消化器内視鏡診療ガイドライン 直接経口凝固薬 (DOAC) を含めた抗凝固薬に関する追補 2017. 日本消化器内視鏡学会雑誌. 2017 ; 59 : 1547-58.
P.134 掲載の参考文献
1) 埼玉県ホームページ. 統計からみた埼玉県市町村のすがた 2019. 人口 世帯. https://www.pref.saitama.lg.jp/a0206/documents/shityouson_no_sugata_2019_jinkou.pdf
P.142 掲載の参考文献
1) Jameson JL, Fauci AS, Kasper DL, et al. Harrison's principles of internal medicine. 17th ed. NY : McGraw-Hill ; 2008.
2) Heath CW Jr, Brodsky AL, Potolsky AI. Infectious monocucleosis in a general population. Am J Epidemiol. 1972 ; 95 : 46-52.
3) Sumaya CV, Ench Y. Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses. Pediatrics. 1895 ; 75 : 1011-9.
4) 形浦昭克. 疾患の病態・治療. 日耳鼻. 1994 ; 97 : 2172-5.
5) Gayer G, Zandman-Goddard G, Kosych E, et al. Spontaneous rapture of the spleen detected on CT as the initial manifestation of infectious mononucleosis. Emerg Radiol. 2003 ; 10 : 51-2.
6) Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010 ; 362 : 1993-2000.
P.151 掲載の参考文献
1) Iwata K, Doi A, Nakamura T, et al. The validity of three sputum smears taken in one day for discontinuing isolation of tuberculosis patients. Int J Tuberc Lung Dis. 2015 ; 19 : 918-20.
2) Hinson JM Jr, Bradsher RW, Bodner SJ. Gram-stain neutrality of Mycobacterium tuberculosis. Am Rev Respir Dis. 1981 ; 123 : 365-6.
3) Kuroda H, Hosokawa N. Gram-ghost bacilli. J Gen Fam Med. 2018 ; 20 : 31-2.
4) Hadano Y. Gram-ghost cells. BMJ Case Rep. 2013.
5) Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med. 2000 ; 161 (4 Pt 2) : S221-47.
6) Pai M, Zwerling A, Menzies D. Systematic review : T-cell-based assays for the diagnosis of latent tuberculosis infection : an update. Ann Intern Med. 2008 ; 149 : 177-84.
7) Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB : a metaanalysis. Chest. 2010 ; 137 : 952-68.
8) Sester M, Sotgiu G, Lange C, et al. Interferon-γ release assays for the diagnosis of active tuberculosis : a systematic review and meta-analysis [published correction appears in Eur Respir J. 2012 Mar ; 39 (3) : 793]. Eur Respir J. 2011 ; 37 : 100-11.
9) Diel R, Goletti D, Ferrara G, et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection : a systematic review and meta-analysis [published correction appears in Eur Respir J. 2012 Mar ; 39 (3) : 793]. Eur Respir J. 2011 ; 37 : 88-99.
10) Komiya K, Ariga H, Nagai H, et al. Impact of peripheral lymphocyte count on the sensitivity of 2 IFN-gamma release assays, QFT-G and ELISPOT, in patients with pulmonary tuberculosis. Intern Med. 2010 ; 49 : 1849-55.
11) Nishiguchi S, Tomiyama S, Kitagawa I, et al. Delayed isolation of smear-positive pulmonary tuberculosis patients in a Japanese acute care hospital. BMC Pulm Med. 2018 ; 18 : 94.
P.154 掲載の参考文献
1) Fukui T. The Ecology of Medical Care in Japan. JMAJ. 2015 ; 48 : 163-7.
2) 厚生労働省. 受療行動調査. 2011.

CHAPTER 3 教育回診の心得と極意

P.164 掲載の参考文献
1) Song EM, Lee HS, Park SH, et al. Clinical characteristics and long-term prognosis of elderly onset ulcerative colitis. J Gastroenterol Hepatol. 2018 ; 33 : 172-9.
2) Ananthakrishnan AN, Shi HY, Tang W, et al. Systematic review and metaanalysis : phenotype and clinical outcomes of older-onset inflammatory bowel disease. J Crohns Colitis. 2016 ; 10 : 1224-36.
P.166 掲載の参考文献
1) Ely JW, Osheroff JA, Ebell MH, et al. Analysis of questions asked by family doctors regarding patient care. BMJ. 1999 ; 319 : 358-61.
P.174 掲載の参考文献
1) 宮野公樹. 研究発表のためのスライドデザイン. 東京 : 講談社 ; 2013.
2) Sato S, Terane A, Nishiguchi S, et al. Intractable hiccups and nausea as a principal symptom of neuromyelitis optica in a patient with a prior history of miller-fisher syndrome. J Gen Fam Med. 2016 ; 17 : 99-104.
3) Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66 : 1485-9.
P.180 掲載の参考文献
1) Culliton BJ. Extracting knowledge from science : A conversation with Elias Zerhouni. Health Affairs. 2006 ; 25 : w94-103.
2) Harrod M. Teaching inpatient medicine : what every physician needs to know first edition. Oxford : Oxford University Press ; 2017.
P.185 掲載の参考文献
1) 日本内科学会. 地方会演題検索『症例くん』. 2019年11月5日確認. https://www.naika.or.jp/meeting/endaikensaku/
2) 國松淳和. はじめての学会発表症例報告. 東京 : 中山書店 ; 2016.
3) 徳田安春. 燃えるフィジカルアセスメント-Gooブログ. 2019年11月5日確認. https://blog.goo.ne.jp/yasuharutokuda

最近チェックした商品履歴

Loading...